1. Home
  2. FENC vs RAC Comparison

FENC vs RAC Comparison

Compare FENC & RAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

SELL

Current Price

$12.49

Market Cap

366.8M

Sector

Health Care

ML Signal

SELL

RAC

Rithm Acquisition Corp. Class A Ordinary Shares

SELL

Current Price

$10.60

Market Cap

310.3M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
FENC
RAC
Founded
1996
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.8M
310.3M
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
FENC
RAC
Price
$12.49
$10.60
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $17.40
N/A
AVG Volume (30 Days)
★ 180.6K
27.6K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.19
N/A
Revenue
★ $44,642,000.00
N/A
Revenue This Year
$67.26
N/A
Revenue Next Year
$42.94
N/A
P/E Ratio
$67.21
★ $35.57
Revenue Growth
N/A
★ N/A
52 Week Low
$5.65
$10.29
52 Week High
$13.25
$10.63

Technical Indicators

Market Signals
Indicator
FENC
RAC
Relative Strength Index (RSI) 65.46 55.26
Support Level $9.58 $10.54
Resistance Level $12.79 N/A
Average True Range (ATR) 0.86 0.01
MACD 0.19 0.00
Stochastic Oscillator 81.90 50.17

Price Performance

Historical Comparison
FENC
RAC

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

About RAC Rithm Acquisition Corp. Class A Ordinary Shares

Rithm Acquisition Corp is a blank check company.

Share on Social Networks: